Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | B. Riley Financial, Inc. RILY |
BlackRock Inc. BLK |
1,544,999 5.100% |
66,701 (+4.51%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Bank7 Corp. BSVN |
BlackRock Inc. BLK |
538,516 5.800% |
538,516 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | BlackSky Technology Inc. BKSY |
BlackRock Inc. BLK |
1,642,300 5.300% |
1,642,300 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Celcuity Inc. CELC |
BlackRock Inc. BLK |
2,179,064 5.900% |
2,179,064 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Chewy, Inc. CHWY |
BlackRock Inc. BLK |
11,781,606 7.300% |
11,781,606 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Compass Therapeutics, Inc. CMPX |
BlackRock Inc. BLK |
6,887,615 5.000% |
6,887,615 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Elanco Animal Health Incorporated ELAN |
BlackRock Inc. BLK |
24,865,467 5.000% |
1,564,357 (+6.71%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BlackRock Inc. BLK |
3,163,180 5.400% |
3,163,180 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
BlackRock Inc. BLK |
1,974,452 5.300% |
1,974,452 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Fractyl Health, Inc. Common Stock GUTS |
BlackRock Inc. BLK |
2,483,635 5.200% |
2,483,635 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | FrontView REIT, Inc. FVR |
BlackRock Inc. BLK |
1,589,962 9.900% |
1,589,962 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Guardian Pharmacy Services, Inc. GRDN |
BlackRock Inc. BLK |
488,323 5.300% |
488,323 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
BlackRock Inc. BLK |
831,807 5.700% |
831,807 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | iShares MSCI Singapore ETF EWS |
BlackRock Inc. BLK |
1,725,415 6.200% |
1,584,648 (+1125.72%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
BlackRock Inc. BLK |
1,821,966 5.500% |
1,821,966 (New Position) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Lyft, Inc. LYFT |
BlackRock Inc. BLK |
21,026,774 5.200% |
4,838,087 (+29.89%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
BlackRock Inc. BLK |
3,840,165 6.300% |
1,468,185 (+61.90%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Shift4 Payments, Inc. FOUR |
BlackRock Inc. BLK |
6,210,689 9.000% |
3,565,949 (+134.83%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | TransUnion TRU |
BlackRock Inc. BLK |
10,643,963 5.500% |
1,124,518 (+11.81%) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
BlackRock Inc. BLK |
5,872,642 5.300% |
408,663 (+7.48%) |
Filing History |